骨移植片・代替物の世界市場2021年-2028年:製品別(同種移植片、骨移植片代替物、細胞ベースマトリックス)、用途別

◆英語タイトル:Bone Grafts and Substitutes Market by Product (Allografts, Bone Grafts Substitutes, and Cell Based Matrices) and Application (Spinal fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting): Global Opportunity Analysis and Industry Forecast, 2021–2028
◆商品コード:AMR21JU049
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2021年5月26日
◆ページ数:228
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥678,480見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥762,190見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,062,930見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、骨移植片・代替物の世界市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、種類別(同種移植、骨移植代替物、セルベースマトリックス(CBM))分析、用途別(脊椎固定術、トラウマ、頭蓋顎顔面手術、関節再建、歯科用骨移植)分析、地域別分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・骨移植片・代替物の世界市場規模:種類別(同種移植、骨移植代替物、セルベースマトリックス(CBM))
・骨移植片・代替物の世界市場規模:用途別(脊椎固定術、トラウマ、頭蓋顎顔面手術、関節再建、歯科用骨移植)
・骨移植片・代替物の世界市場規模:地域別
・企業情報
【レポートの概要】

Bone grafts are implantable materials that promote bone healing through its osteoconductive, osteogenic, and osteoinductive mechanisms. The bone grafts are used in surgical procedures such as spinal fusion surgeries, bone replacement, ensuring new bone formation, and repair of bone fractures. Moreover, bone grafting has applications in the treatment of various bone related disorders such as congenital pseudoarthrosis, dental bone grafting problems, and complex fractures. Allografts, synthetic bone grafts, and demineralized bone matrix are the most commonly used bone grafts worldwide.

The global bone grafts & substitutes market was valued at $2,652.6 million in 2020, and is projected to reach $3,362.6 million by 2028, registering a CAGR of 4.3% from 2021 to 2028. Rise in incidences of musculoskeletal disorders, development of biocompatible synthetic bone grafts, technological advancements in medical field leading to a shift from autograft to allograft drive the growth of the bone grafts & substitutes market. For instance, as per the data published by World Health Organization (WHO), in 2021, musculoskeletal conditions are the prominent contributors to disability globally, with low back pain being the single primary cause of disability in 160 countries or early deaths. Low back pain causes the greatest burden with a prevalence of 568 million people and this trend is expected to continue for next few years.

In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuel the growth of the market. For instance, according to IDF Diabetes Atlas, Ninth Edition 2019, approximately 463 million adults had diabetes and by 2045, the number is estimated to increase to 700 million across the world. Apart from this, more than 1.1 million children were suffering from type 1 diabetes in 2019, which reveals the severity of this disease. Increase in incidences of diabetic cases leading to degenerative joint disorders is expected to provide high market growth and opportunities in near future. On the other hand, high cost of surgeries and ethical issues related with bone grafting procedures restrict the market growth. Conversely, emerging markets, rise in interests of key players toward R&D activities in bone grafts and its substitutes, and increase in demand for orthopedic procedures particularly in geriatric population are expected to provide profitable opportunities for the growth of the market in near future.

The research report categorizes the bone graft & substitute market based on product type, application, and region. By product type, it is classified into allografts, bone grafts substitutes, and cell-based matrices. The allografts are further categorized to machined allografts and demineralized bone matrix. The bone graft substitutes segment is further classified into bone morphogenic proteins (BMP) and synthetic bone grafts. By application, it is divided into spinal fusion, trauma, craniomaxilofacial, joint reconstruction, and dental bone grafting. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

This market has witnessed several product launches and approvals over the past few years. This is evident from the strategic launch of cryopreserved osteochondral allograft, ProChondrixCR by Stryker Corporate, in April 2018, while the NuVasive launched AttraX Scaffold Biologic an absorbent ceramic-collagen bone graft with an optimized surface, in June 2018. Key players profiled in this report include Arthrex, Inc., Baxter International Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive, Inc., Stryker Corporation, Xtant Medical Holdings, Inc., Inc., and Zimmer Biomet Holdings, Inc.

KEY BENEFITS FOR STAKEHOLDERS
 The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
 The report provides a quantitative analysis for the period of 2021–2028 to enable stakeholders to capitalize on the prevailing market opportunities.
 Extensive analysis of the market based on products helps understand the type of devices used to treat musculoskeletal disorders and degenerative joints diseases.
 Competitive intelligence highlights the business practices followed by leading players across various regions.
 Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.
 Key market players and their strategies are analysed to understand the competitive outlook of the overall market.
 Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS
By Product
• Allografts
o Machined allografts
o Demineralized bone matrix
• Bone Grafts Substitutes
o Bone morphogenic proteins (BMP)
o Synthetic bone grafts
• Cell based matrices

By Application
• Spinal fusion
• Trauma
• Craniomaxillofacial
• Joint reconstruction
• Dental bone grafting

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

KEY MARKET PLAYERS
• Arthrex, Inc.
• Baxter International Inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson ( DePuy Synthes )
• Medtronic Plc.
• Musculoskeletal Transplant Foundation
• NuVasive, Inc.
• Stryker Corporation
• Xtant Medical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market share analysis, 2020
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in incidences of musculoskeletal conditions
3.4.1.2.Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3.Development of biocompatible synthetic bone grafts
3.4.1.4.Obesity and diabetes to increase the risk of degenerative joint diseases

3.4.2.Restraints

3.4.2.1.High cost of surgeries
3.4.2.2.Ethical issues related with bone grafting procedures

3.4.3.Opportunities

3.4.3.1.Emerging markets to offer lucrative growth opportunities

3.5.Government Regulations

3.5.1.FDA
3.5.2.Health Canada
3.5.3.CE Mark
3.5.4.Ministry of Health, Labor and Welfare (MHLW)
3.5.5.Therapeutic Goods Administration (TGA)

3.6.Reimbursement Scenario

3.6.1.U.S.
3.6.2.Europe
3.6.3.Asia-Pacific
3.6.4.LAMEA

3.7.COVID-19 Impact analysis on the market

CHAPTER 4:BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Allografts

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.2.5.Machined Allografts

4.2.5.1.Market size and forecast

4.2.6.Demineralized Bone Matrix (DBM)
4.2.6.1.Market size and forecast

4.3.Bone Graft Substitutes

4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.3.5.Bone Morphogenic Proteins (BMP)

4.3.5.1.Market size and forecast

4.3.6.Synthetic Bone Grafts

4.3.6.1.Market size and forecast

4.4.Cell-based Matrices (CBM)

4.4.1.Key market trends, growth factors and opportunities
4.4.1.1.Cell-based matrices-major products
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Spinal Fusion

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Trauma

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Craniomaxillofacial Surgery

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Joint Reconstruction

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

5.6.Dental Bone Grafting

5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:BONE GRAFTS & SUBSTITUTES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. Bone grafts & substitutes market by type
6.2.2.1.2.U.S. Bone grafts & substitutes market by application

6.2.2.2.Canada

6.2.2.2.1.Canada Bone grafts & substitutes market by type
6.2.2.2.2.Canada Bone grafts & substitutes market by application

6.2.2.3.Mexico

6.2.2.3.1.Mexico Bone grafts & substitutes market by type
6.2.2.3.2.Mexico Bone grafts & substitutes market by application

6.2.3.Market size and forecast, by type
6.2.4.Market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany Bone grafts & substitutes market by type
6.3.2.1.2.Germany Bone grafts & substitutes market by application

6.3.2.2.France

6.3.2.2.1.France Bone grafts & substitutes market by type
6.3.2.2.2.France Bone grafts & substitutes market by application

6.3.2.3.Italy

6.3.2.3.1.Italy Bone grafts & substitutes market by type
6.3.2.3.2.Italy Bone grafts & substitutes market by application

6.3.2.4.Spain

6.3.2.4.1.Spain Bone grafts & substitutes market by type
6.3.2.4.2.Spain Bone grafts & substitutes market by application

6.3.2.5.UK

6.3.2.5.1.UK Bone grafts & substitutes market by type
6.3.2.5.2.UK Bone grafts & substitutes market by application

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe Bone grafts & substitutes market by type
6.3.2.6.2.Rest of Europe Bone grafts & substitutes market by application

6.3.3.Market size and forecast, by type
6.3.4.Market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.Japan

6.4.2.1.1.Japan Bone grafts & substitutes market, by type
6.4.2.1.2.Japan Bone grafts & substitutes market, by application

6.4.2.2.China

6.4.2.2.1.China Bone grafts & substitutes market, by type
6.4.2.2.2.China Bone grafts & substitutes market, by application

6.4.2.3.India

6.4.2.3.1.India Bone grafts & substitutes market, by type
6.4.2.3.2.India Bone grafts & substitutes market, by application

6.4.2.4.Australia

6.4.2.4.1.Australia Bone grafts & substitutes market, by type
6.4.2.4.2.Australia Bone grafts & substitutes market, by application

6.4.2.5.South Korea

6.4.2.5.1.South Korea Bone grafts & substitutes market, by type
6.4.2.5.2.South Korea Bone grafts & substitutes market, by application

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific Bone grafts & substitutes market, by type
6.4.2.6.2.Rest of Asia-Pacific Bone grafts & substitutes market, by application

6.4.3.Asia-Pacific Bone grafts &substitutes market, by type
6.4.4.Asia-Pacific Bone grafts & substitutes market, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil bone grafts & substitutes market, by type
6.5.2.1.2.Brazil bone grafts & substitutes market, by application

6.5.2.2.Israel

6.5.2.2.1.Israel bone grafts & substitutes market, by type
6.5.2.2.2.Israel bone grafts & substitutes market, by application

6.5.2.3.Saudi Arabia

6.5.2.3.1.Saudi Arabia bone grafts & substitutes market, by type
6.5.2.3.2.Saudi Arabia bone grafts & substitutes market, by application

6.5.2.4.South Africa

6.5.2.4.1.South Africa bone grafts & substitutes market, by type
6.5.2.4.2.South Africa bone grafts & substitutes market, by application

6.5.2.5.Rest of LAMEA

6.5.2.5.1.Rest of LAMEA bone grafts & substitutes market, by type
6.5.2.5.2.Rest of LAMEA bone grafts & substitutes market, by application

6.5.3.Market size and forecast, by type
6.5.4.Market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.ARTHREX, INC.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product Portfolio

7.2.BAXTER INTERNATIONAL INC.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product Portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments

7.3.INTEGRA LIFESCIENCES HOLDINGS CORPORATION

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance

7.4.JOHNSON & JOHNSON (DEPUY SYNTHES)

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product Portfolio
7.4.5.Business performance

7.5.MEDTRONIC PLC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.MUSCULOSKELETAL TRANSPLANT FOUNDATION

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product Portfolio

7.7.NUVASIVE, INC.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product Portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.STRYKER CORPORATION

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.XTANT MEDICAL HOLDINGS, INC.

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product Portfolio
7.9.5.Business performance

7.10.ZIMMER BIOMET HOLDINGS, INC.,

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance

LIST OF TABLES

TABLE 01.BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020 2028 ($MILLION)
TABLE 02.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFT, BY TYPE 2020-2028 ($MILLION)
TABLE 03.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY REGION 2020-2028 ($MILLION)
TABLE 04.BONE GRAFTS & SUBSTITUTES MARKET FOR MACHINED ALLOGRAFTS, BY REGION , 2020-2028 ($MILLION)
TABLE 05.BONE GRAFTS & SUBSTITUTES MARKET FOR DEMINERALIZED BONE MATRIX, BY REGION, 2020-2028 ($MILLION)
TABLE 06.BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2020-2028
TABLE 07.BONE GRAFTS SUBSTITUTES MARKET, BY REGION ($MILLION), 2020-2028
TABLE 08.BONE GRAFTS & SUBSTITUTES MARKET FOR BONE MORPHOGENETIC PROTEIN, BY REGION, 2020-2028 ($MILLION)
TABLE 09.BONE GRAFTS & SUBSTITUTES MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020 & 2028 ($MILLION)
TABLE 10.CELL-BASED MATRICES- MAJOR PRODUCTS AND STRATEGIES
TABLE 11.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY REGION, 2020 & 2028 ($MILLION)
TABLE 12.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 ($MILLION),
TABLE 13.BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020 & 2028 ($MILLION)
TABLE 14.BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY REGION, 2020 & 2028 ($MILLION)
TABLE 15.BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY REGION 2020 & 2028 ($MILLION)
TABLE 16.BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY REGION 2020 & 2028 ($MILLION)
TABLE 17.BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY REGION, 2020 & 2028 ($MILLION)
TABLE 18.BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY REGION, 2020 & 2028 ($MILLION)
TABLE 19.BONE GRAFTS & SUBSTITUTES MARKET, BY REGION, 2020 - 2028 ($MILLION)
TABLE 20.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 21.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 22.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 23.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 24.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 25.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 26.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 27.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 28.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021–2028 ($MILLION)
TABLE 29.EUROPE BONE GRAFTS & SUBSTITUTES, BY COUNTRY 2020–2028 ($MILLION)
TABLE 30.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 31.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 32.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 33.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 34.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 35.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 36.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 37.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 38.UK BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 39.UK BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 40.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 41.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 42.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 43.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 44.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 45.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 46.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 47.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 48.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 49.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 50.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 51.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 52.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 53.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 54.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 56.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 57.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 58.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 59.LAMEA BONE GRAFTS & SUBSTITUTES, BY COUNTRY ($MILLION), 2020–2028
TABLE 60.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 61.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 62.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 63.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021–2028 ($MILLION)
TABLE 64.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 65.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 66.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 67.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 68.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 69.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 70.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 71.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 72.ARTHREX: COMPANY SNAPSHOT
TABLE 73.ARTHREX: PRODUCT CATEGORIES
TABLE 74.ARTHREX: PRODUCT PORTFOLIO
TABLE 75.BAXTER: COMPANY SNAPSHOT
TABLE 76.BAXTER: BUSINESS UNITS
TABLE 77.BAXTER: PRODUCT PORTFOLIO
TABLE 78.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79.INTEGRA: COMPANY SNAPSHOT
TABLE 80.INTEGRA: OPERATING SEGMENTS
TABLE 81.INTEGRA: PRODUCT PORTFOLIO
TABLE 82.J&J: COMPANY SNAPSHOT
TABLE 83.J&J: OPERATING SEGMENTS
TABLE 84.J&J: PRODUCT PORTFOLIO
TABLE 85.MEDTRONIC: COMPANY SNAPSHOT
TABLE 86.MEDTRONIC: OPERATING SEGMENTS
TABLE 87.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.MTF BIOLOGICS: COMPANY SNAPSHOT
TABLE 90.MTF BIOLOGICS: PRODUCT OFFERINGS
TABLE 91.MTF BIOLOGICS: PRODUCT PORTFOLIO
TABLE 92.NUVASIVE: COMPANY SNAPSHOT
TABLE 93.NUVASIVE: PRODUCT LINE
TABLE 94.NUVASIVE: PRODUCT PORTFOLIO
TABLE 95.NUVASIVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.STRYKER: COMPANY SNAPSHOT
TABLE 97.STRYKER: OPERATING SEGMENTS
TABLE 98.STRYKER: PRODUCT PORTFOLIO
TABLE 99.STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.XTNT: COMPANY SNAPSHOT
TABLE 101.XTNT: OPERATING SEGMENTS
TABLE 102.XTNT: PRODUCT PORTFOLIO
TABLE 103.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 104.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 105.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.SEGMENTATION: BONE GRAFTS & SUBSTITUTES MARKET
FIGURE 02.TOP INVESTMENT POCKETS: BONE GRAFTS & SUBSTITUTES MARKET
FIGURE 01.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2018–2021*
FIGURE 02.TOP WINNING STRATEGIES: BY DEVELOPMENT, 2018-2021* (%)
FIGURE 03.TOP WINNING STRATEGIES: BY COMPANY, 2018-2021* (%)
FIGURE 01.MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2020
FIGURE 02.MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2020
FIGURE 03.MARKET SHARE ANALYSIS: DEMINERALISED BONE MATRIX, 2020
FIGURE 04.MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2020
FIGURE 05.MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2020
FIGURE 06.MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2020
FIGURE 07.MARKET DYNAMICS
FIGURE 08.BONE GRAFTS & SUBSTITUTES MARKET: BY PRODUCT TYPE
FIGURE 09.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY COUNTRY, 2020 & 2028(%)
FIGURE 10.COMPARATIVE ANALYSIS OF BONE GRAFTS SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY COUNTRY, 2020 & 2028 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY COUNTRY, 2020 & 2028 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY COUNTRY, 2020 & 2028 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.BAXTER: NET SALES, 2018–2020 ($MILLION)
FIGURE 18.BAXTER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 19.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 20.INTEGRA: NET SALES, 2018–2020 ($MILLION)
FIGURE 21.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22.INTEGRA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.J&J: REVENUE, 2018–2020 ($MILLION)
FIGURE 24.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29.NUVASIVE: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.NUVASIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.NUVASIVE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32.STRYKER: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.STRYKER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.XTNT: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.XTNT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.XTNT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.ZIMMER BIOMET: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[骨移植片・代替物の世界市場2021年-2028年:製品別(同種移植片、骨移植片代替物、細胞ベースマトリックス)、用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆